Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones.
Ominsky MS, Li C, Li X, Tan HL, Lee E, Barrero M, Asuncion FJ, Dwyer D, Han CY, Vlasseros F, Samadfam R, Jolette J, Smith SY, Stolina M, Lacey DL, Simonet WS, Paszty C, Li G, Ke HZ.
Ominsky MS, et al. Among authors: lee e.
J Bone Miner Res. 2011 May;26(5):1012-21. doi: 10.1002/jbmr.307.
J Bone Miner Res. 2011.
PMID: 21542004
Free article.